MPN-associated thrombosis is considered a multifactorial event involving the complex interplay of blood and endothelial cells, the coagulation cascade, JAK2 mutation allele burden, and chronic inflammation, all of which likely contribute to the prothrombotic phenotype (4). This evidence concerns the gene JAK2 and myeloproliferative neoplasm.